Approval · Notice of Compliance 38442 · 2026
DOXYCIN CAPSULES: Notice of Compliance 38442
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38442
- Date
- October 9, 2026
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with supporting PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOXYCIN CAPSULES | Not yet assigned | — |
| DOXYCIN TABLETS | Not yet assigned | — |
Medicinal ingredients
- DOXYCYCLINE HYCLATE 100 MG per CAP
- DOXYCYCLINE HYCLATE 100 MG per TAB